Results
Revise Search
-
Filters:
- "BR2019-05" OR "PD19-02" OR "PD19-01" OR "BR2018-15" OR "BR2018-13" OR "BR2018-04" OR "PD18-01" OR "GC17-06" OR "BR2017-05" OR "BR2017-15" OR "GC16-30" OR "BR2016-04" OR "PD15-06" OR "BR2015-02" OR "GC14-55" OR "BR2014-12" OR "BR2014-04" OR "BR2014-03" OR "BR2014-02" OR "GC12-72"
- 2013
- 2015
- 2017
The Need for a National Strategy to Address Abuse and Misuse of Prescription Drugs in Canada: Canadian Medical Association Submission to the House of Commons Standing Committee on Health
https://policybase.cma.ca/en/permalink/policy11035
- Date
- 2013-11-27
- Topics
- Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
1 document
Harms associated with opioids and other psychoactive prescription drugs
https://policybase.cma.ca/en/permalink/policy11535
- Date
- 2015-05-30
- Topics
- Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
1 document
CMA submission to the study of Bill C-37
https://policybase.cma.ca/en/permalink/policy13617
- Date
- 2017-04-06
- Topics
- Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
1 document
Opioid overdose prevention supplies available in publicly accessible locations
https://policybase.cma.ca/en/permalink/policy13703
- Date
- 2017-08-23
- Topics
- Health care and patient safety
- Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
- Resolution
- GC17-06
- The Canadian Medical Association supports making naloxone and other opioid overdose prevention supplies available in publicly accessible locations.
- Policy Type
- Policy resolution
- Date
- 2017-08-23
- Resolution
- GC17-06
- The Canadian Medical Association supports making naloxone and other opioid overdose prevention supplies available in publicly accessible locations.
Physician health
https://policybase.cma.ca/en/permalink/policy13739
- Date
- 2017-10-21
- Topics
- Health human resources
- Ethics and medical professionalism
3 documents
- Policy Type
- Policy document
- Date
- 2017-10-21
- Replaces
- PD98-04 Physician health and well-being
Documents
Non-prescription availability of low-dose codeine products
https://policybase.cma.ca/en/permalink/policy13734
- Date
- 2017-11-7
- Topics
- Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
1 document
